Strides and Obstacles in Melanoma Research Spotlight on Martin McMahon, PhD
Like so many in the melanoma research field, Martin McMahon, PhD, Huntsman Cancer Institute’s senior director of pre-clinical translation and Professor at the University of Utah, entered the melanoma field by accident.
Invincible, Until You’re Not
Self described, lifetime sun worshiper and tanning bed devotee, 24-year old native Texan Ali Young was barely daunted the first time she was diagnosed with deadly skin cancer at the age of 18. Matter of fact, she recalls heading to the tanning bed the very day after her biopsy.
Melanoma Clinical Oncology Research: Interview with Dr. Joshua Arbesman
By Pooja H. Rambhia, MD Candidate, Case Western Reserve University | 6 June 2017 In Science, Treatment
As a third year medical student, MD Candidate Pooja Rambhia had the privilege of conducting an elective research year under Dr. Joshua Arbesman’s mentorship at University Hospitals Cleveland Medical Center. Arbesman has a unique role in translational basic science research within the realm of familial melanoma.
The Genetics of Melanoma Goes Deep
By Kristen Mueller, Ph.D., MRA Scientific Program Director | 6 June 2017 In News, Science, Treatment
Due to the rapid advancements in DNA sequencing technologies, our understanding of the underlying genetic causes of cancer has increased substantially in the past decade. In the case of melanoma, researchers have now characterized in great detail the genetic changes that occur within tumor cells in melanoma of the skin, leading to the FDA approval of drugs targeting mutations in BRAF and MEK.
LFFM Fundraising Event Again Reaches a Record Setting Year
Nearly 1,000 professionals from the leveraged finance community gathered for the sixth annual Leveraged Finance Fights Melanoma (LFFM) benefit and cocktail party raising a record $1.8 million in funds for the Melanoma Research Alliance (MRA), the largest private funder of melanoma research.
What Gut Bacteria Tell Us About Treating Melanoma and Other Cancers
Despite success in the use of immunotherapy to treat cancer by harnessing the body’s immune system to fight it, a major difficulty continues to be the range of responses to treatment among patients. It’s why researchers are exploring why some cancer patients exhibit astounding results with little side effects while others receive no benefits to the treatment and/or experience severe side effects.
MRA and BJ’s Wholesale Club Partner to Launch May Campaign
In today’s dynamic research environment, working as a team is more valuable than ever. This May, in an effort to spotlight Melanoma Awareness month, BJ’s Wholesale Club, a warehouse club operating in 15 states and headquartered in Massachusetts, will launch its first awareness campaign in partnership with MRA to highlight the importance of prevention.
Taking Charge of the Skin You’re In: 3 Levels of Melanoma Prevention and Detection
By Pooja H. Rambhia, MD Candidate, Case Western Reserve University | 3 April 2017 In Melanoma Stories, Prevention, Treatment
No healthy person in their twenties expects they’re going to get a call one day telling them they have an invasive nodular melanoma. Despite seeing and hearing of horrible stories about young patients developing cancers, we can’t imagine it’ll happen to us. That element of surprise is exactly what 25-year-old medical student, Alissa Prior, experienced upon hearing her diagnosis.
Finance Industry Rallies to Fight Melanoma
Spotlighted in publications like Forbes, Bloomberg and The New York Times, the Leveraged Finance Fights Melanoma (LFFM) event, sponsored annually in New York City by the Melanoma Research Alliance (MRA) has become the premier gathering of professionals from the leveraged finance, private equity, and investment communities – all gathered together in response to melanoma.
Polka Dot Mama Melanoma Foundation Launches Shade Shuttle Bus Tour
By Pamela Goldsmith, MRA Director of Communications | 2 April 2017
Taking her advocacy to the next level, Tracy Callahan, along with the Tara Miller Melanoma Foundation, is about to launch Shade Shuttle, a multi-state bus tour dedicated to raising awareness and educating the community about melanoma.
Adjuvant Therapy Advocacy ASCO Awareness Biopharma Board Members BRAF Cancer Combination Therapy Detection FDA Francis Collins Grants Health HHS Immunotherapy Louise Perkins Melanoma microbiome MRA News Nonprofits Partners Patient Forum Patient Stories Patient-Centric Care Patients Pediatric Melanoma Prevention Redheads Research Science Social Media Surgeon General Surgeon General's Call to Action to Prevent Skin Cancer Targeted Therapy Teens Treatment Wendy Selig Young Investigators Young People